{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:06Z","timestamp":1786123386062,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1213\/ane.0b013e3182691c11","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T15:02:45Z","timestamp":1344870165000},"page":"1290-1295","source":"Crossref","is-referenced-by-count":4,"title":["Vasopressin-Mediated Enhancement of Adrenergic Vasoconstriction Involves Both the Tyrosine Kinase and the Protein Kinase C Pathways"],"prefix":"10.1213","volume":"115","author":[{"given":"Jochen","family":"Steppan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sine\u00e1d M.","family":"Nyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artin A.","family":"Shoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan E.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210902","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccc.2009.12.005","article-title":"Mean arterial pressure: therapeutic goals and pharmacologic support.","volume":"26","author":"Shapiro","year":"2010","journal-title":"Crit Care Clin"},{"key":"R2-8-20210902","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/0003-4975(96)00055-0","article-title":"Systemic inflammatory response syndrome after cardiac operations.","volume":"61","author":"Cremer","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R3-8-20210902","doi-asserted-by":"crossref","first-page":"642462","DOI":"10.1155\/2010\/642462","article-title":"Novel insights for systemic inflammation in sepsis and hemorrhage.","volume":"2010","author":"Cai","year":"2010","journal-title":"Mediators Inflamm"},{"key":"R4-8-20210902","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.ccx.0000145099.20822.19","article-title":"ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction.","volume":"10","author":"Pollesello","year":"2004","journal-title":"Curr Opin Crit Care"},{"key":"R5-8-20210902","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside.","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"R6-8-20210902","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock.","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"key":"R7-8-20210902","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock.","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"R8-8-20210902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(92)90067-5","article-title":"Signal transduction of V1-vascular vasopressin receptors.","volume":"38","author":"Thibonnier","year":"1992","journal-title":"Regul Pept"},{"key":"R9-8-20210902","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00000542-199409000-00017","article-title":"Pulmonary vasoregulation by arginine vasopressin in conscious, halothane-anesthetized, and pentobarbital-anesthetized dogs with increased vasomotor tone.","volume":"81","author":"Trempy","year":"1994","journal-title":"Anesthesiology"},{"key":"R10-8-20210902","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.","volume":"107","author":"Dunser","year":"2003","journal-title":"Circulation"},{"key":"R11-8-20210902","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjp.0701397","article-title":"Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.","volume":"122","author":"Noguera","year":"1997","journal-title":"Br J Pharmacol"},{"key":"R13-8-20210902","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.HYP.0000198543.34502.d7","article-title":"Knockdown of arginase I restores NO signaling in the vasculature of old rats.","volume":"47","author":"White","year":"2006","journal-title":"Hypertension"},{"key":"R14-8-20210902","doi-asserted-by":"crossref","first-page":"H757","DOI":"10.1152\/ajpheart.00142.2011","article-title":"PKCalpha mediates acetylcholine-induced activation of TRPV4-dependent calcium influx in endothelial cells.","volume":"301","author":"Adapala","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R15-8-20210902","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1124\/mol.107.038091","article-title":"Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells.","volume":"73","author":"Lee","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R16-8-20210902","first-page":"H1009","article-title":"Pulmonary vasoactive effects of exogenous and endogenous AVP in conscious dogs.","volume":"251","author":"Nyhan","year":"1986","journal-title":"Am J Physiol"},{"key":"R17-8-20210902","first-page":"H493","article-title":"AVP-induced pulmonary vasodilation during specific V1 receptor block in conscious dogs.","volume":"253","author":"Nyhan","year":"1987","journal-title":"Am J Physiol"},{"key":"R18-8-20210902","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/0310057X0002800312","article-title":"Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.","volume":"28","author":"Lim","year":"2000","journal-title":"Anaesth Intensive Care"},{"key":"R19-8-20210902","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj20030312","article-title":"Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2.","volume":"374","author":"Werry","year":"2003","journal-title":"Biochem J"},{"key":"R20-8-20210902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I","article-title":"Role of phospholipase C and D signalling pathways in vasopressin-dependent myogenic differentiation.","volume":"171","author":"Naro","year":"1997","journal-title":"J Cell Physiol"},{"key":"R21-8-20210902","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0898-6568(99)00035-2","article-title":"Homologous and heterologous phosphorylation of the vasopressin V1a receptor.","volume":"11","author":"Ancellin","year":"1999","journal-title":"Cell Signal"},{"key":"R23-8-20210902","first-page":"H971","article-title":"Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells.","volume":"273","author":"Zhang","year":"1997","journal-title":"Am J Physiol"},{"key":"R24-8-20210902","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0003-9861(03)00226-1","article-title":"Modulation of ANP-C receptor signaling by arginine-vasopressin in A-10 vascular smooth muscle cells: role of protein kinase C.","volume":"415","author":"Boumati","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"R25-8-20210902","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-5793(91)80721-E","article-title":"Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells.","volume":"285","author":"Tsuda","year":"1991","journal-title":"FEBS Lett"},{"key":"R26-8-20210902","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005344-200207000-00015","article-title":"Tyrosine kinase inhibition attenuates vasopressin-induced contraction of mesenteric resistance arteries: alterations in spontaneously hypertensive rats.","volume":"40","author":"Endemann","year":"2002","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3182691c11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:50Z","timestamp":1786112390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201212000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3182691c11","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}